Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Prostate|May 21, 2016
Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic diseaseAhmed Larbi, Benjamin Dallaudière, Vasiliki Pasoglou, et al.
European Radiology|January 14, 2022
Application of diffusion-weighted whole-body MRI for response monitoring in multiple myeloma after chemotherapy: a systematic review and meta-analysisKaiwen Wang, Elsa Lee, Shedrack Kenis, et al.
Insights Into Imaging|July 9, 2026
Integrating MRI-based tumour staging within the TNM classification system in modern prostate cancer managementGeorgios Agrotis, Andrei Purysko, Anwar Padhani, et al.
Radiology|August 25, 2005
Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysisRuth M L Warren, Linda Pointon, Deborah Thompson, et al.
BMJ Open|October 5, 2018
Can the completeness of radiological cancer staging reports be improved using proforma reporting? A prospective multicentre non-blinded interventional study across 21 centres in the UKAnisha Patel, Andrea Rockall, Ashley Guthrie, et al.
Ebiomedicine|July 31, 2016
Radiogenomics Monitoring in Breast Cancer Identifies Metabolism and Immune Checkpoints as Early Actionable Mechanisms of Resistance to Anti-angiogenic TreatmentShaveta Mehta, Nick P Hughes, Sonia Li, et al.
Clinical Genitourinary Cancer|May 7, 2021
Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223Adham Hijab, Sebastian Curcean, Nina Tunariu, et al.
Radiology|February 27, 2019
Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)Christina Messiou, Jens Hillengass, Stefan Delorme, et al.
Health Technology Assessment (Winchester, England)|December 20, 2019
Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studiesStuart A Taylor, Susan Mallett, Anne Miles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study GroupRobert A Huddart, Michael J O'Doherty, Anwar Padhani, et al.
Pageof 3